期刊文献+

氢氯噻嗪分别同氯沙坦与苯那普利联用治疗慢性心功能不全对血尿酸的影响 被引量:1

暂未订购
导出
摘要 目的探讨血管紧张素Ⅱ受体拮抗剂氯沙坦和氢氯噻嗪合用治疗慢性心功能不全患者,对血尿酸的影响。方法回顾分析64例慢性心功能不全患者,其中氯沙坦与氢氯噻嗪联用组32例,对照组为苯那普利与氢氯噻嗪联用组32例。观察两组患者入院时血尿酸与入院后2周血尿酸变化。结果氯沙坦组血尿酸降低显著(P<0.05),两组间差异有显著性意义(P<0.05)。结论氯沙坦治疗合并血尿酸升高的慢性心功不全患者可使血尿酸下降,既使与氢氯噻嗪联用仍有明显的降血尿酸作用。
作者 马龙彪
出处 《辽宁医学杂志》 2007年第2期133-134,共2页 Medical Journal of Liaoning
  • 相关文献

参考文献6

二级参考文献19

  • 1Moriarity JT,Folsom AR,Iribarren C,et al.Serum uric acid and risk of coronary heart disease:Atherosclerosis Risk in Communities(ARIC) Study.Ann Epidemiol,2000,10:136-143.
  • 2Breckenridge A.Hypertension and hyperuricaemia.Lancet,1966,1:15-18.
  • 3Cannon PJ,Stason WB,demartini FE,et al.Hyperurcemia in primary and renal hypertension.N Engl J Med,1966,275:457-464
  • 4Johnson RJ,Kang DH,Feig D,et al.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease.?Hypertension,2003,41:1183-1190.
  • 5Hoieggen A,Alderman MH,Kjeldsen SE,et al.The impact of serum uric acid on cardiovascular outcomes in the LIFE study.Kidney Int,2004,65:1041-1049.
  • 6孟昭亨.尿酸与痛风.见:方圻,主编.现代内科学.北京:人民军医出版社,1995.2868-2878.
  • 7Nakashima M,Uematsu T,Kosuge K,et al.Pilot study of the uricosuric effect of DuP-753,a new angiotensin Ⅱ receptor antagonist,in healthy subjects.Eur J Clin Pharmacol,1992,42:333-335.
  • 8Sweet CS,Bradstreet DC,Berman RS,et al.Pharmacodynamic activity of intravenous E-3174,an angiotensin Ⅱ antagonist,in patients with essential hypertension.Am J Hypertens,1994,7:1035 -1040.
  • 9Wurzner G,Gester JC,Chiolero A,et al.Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.J Hypertens,2001,19:1855-1860.
  • 10Takahashi S,Moriwaki Y,Yamamoto T,et al.Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.Ann Rheum Dis,2003,62:572-575.

共引文献67

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部